R-115777: an oral protein farnesyltransferase inhibitor with activity in advanced breast cancer Dec. 19, 2000
Combinations of exisulind and Herceptin or Taxotere synergistic in human breast cancer cells Dec. 19, 2000
Multitargeted antifolate as salvage therapy in refractory/resistant metastatic breast cancer Dec. 19, 2000
Schering AG and Jenapharm jointly develop highly potent, selective and pure progesterone antagonist Dec. 19, 2000
Potent MMP inhibitor delays osteolytic disease associated with breast cancer metastasis Dec. 18, 2000
RSS